Tirzepatide prescribed by telehealth is fully legal in Michigan, and compounded pricing typically runs well below brand-name cost.
Luma Health's compounded tirzepatide is $297/month, flat, available to residents of Michigan through a standard online medical evaluation — no local clinic visit required.
Patients in Michigan looking into compounded tirzepatide have more legitimate options today than a couple of years ago, but the market includes a wide range of pricing and pharmacy quality. Here's what actually matters when comparing options if you live in Michigan.
Is Telehealth Tirzepatide Legal in Michigan?
Yes. Telehealth prescribing of GLP-1 medications, including compounded tirzepatide, is legal in Michigan when conducted by a provider licensed to practice in Michigan following a genuine medical evaluation. Michigan's Board of Pharmacy, under the Department of Licensing and Regulatory Affairs (LARA), oversees pharmacy and compounding licensure statewide. As with any state, the legitimacy of a specific offer depends on the provider actually being licensed in Michigan and the pharmacy being properly licensed to dispense there — not on the medication itself being restricted.
What Tirzepatide Typically Costs in Michigan
Brand-name tirzepatide without insurance commonly runs well over $1,000/month at retail pharmacies. Local weight-loss clinics offering compounded versions in-person often charge somewhere in the $300-600/month range, depending on the clinic and dose. Compounded tirzepatide through licensed telehealth tends to be more affordable than either of those paths, though pricing varies meaningfully across providers — some advertise low starter-dose rates that increase at therapeutic maintenance doses, while others use a flat rate.
Luma Health's tirzepatide is priced flat at $297/month regardless of dose, which means your cost doesn't increase as your provider adjusts your dose upward over time.
Confirm any compounding pharmacy's license directly with the Michigan Board of Pharmacy (LARA): https://www.michigan.gov/lara/bureau-list/bpl/health/hp-lic-health-prof/pharmacy. Luma Health's compounded medications are prepared by VialsRx, licensed by the Texas State Board of Pharmacy (license #35264), which you can verify at pharmacy.texas.gov.
How Getting Started Works in Michigan
- Complete an online health questionnaire covering your medical history, current weight, and goals
- A licensed provider reviews your information and evaluates eligibility (generally BMI ≥30, or ≥27 with a weight-related condition)
- If appropriate, your prescription is sent to a licensed 503A compounding pharmacy
- Medication ships directly to your Michigan address, typically within a few business days
- Ongoing dose adjustments and check-ins happen through your provider, without needing to visit a local clinic
What About Semaglutide?
Luma Health also offers compounded semaglutide at $197/month for Michigan residents who may be a better fit for that medication based on their health profile — the two work through overlapping but distinct mechanisms, and a provider evaluation is the right way to determine which fits your situation, rather than assuming one is universally better. For a deeper look at how the two compare clinically, see our semaglutide vs. tirzepatide breakdown.
Who Should Consider Compounded Treatment in Michigan
- Don't have insurance coverage for weight-loss GLP-1s
- Meet FDA-aligned BMI eligibility criteria
- Want flat, predictable monthly pricing
- Prefer avoiding local clinic visits
- Have a personal or family history of medullary thyroid carcinoma or MEN2
- Have a history of pancreatitis
- Are pregnant, breastfeeding, or planning pregnancy
- Have significant kidney or gastrointestinal disease
Start your evaluation
from anywhere in Michigan
Compounded tirzepatide at $297/month, flat — medical evaluation, provider visits, and shipping all included.
Get Started → Or start your free health assessmentFrequently Asked Questions
Yes, when prescribed by a provider licensed in Michigan following a genuine medical evaluation, and dispensed by a properly licensed compounding pharmacy. The medication itself isn't restricted in Michigan; legitimacy depends on proper licensing at every step.
Local in-person clinics in Michigan commonly charge $300-600/month for compounded versions, while brand-name options run well over $1,000/month without insurance. Luma Health's telehealth price is $297/month, flat.
No. The entire process, from medical evaluation to prescription to delivery, happens online. Medication ships directly to your Michigan address.
Check the pharmacy's license directly with the state board of pharmacy where it's located — for Luma Health, that's the Texas State Board of Pharmacy at pharmacy.texas.gov. You can also check Michigan's own board, the Michigan Board of Pharmacy (LARA), for general licensing guidance.
Semaglutide is a GLP-1 receptor agonist; tirzepatide activates both GLP-1 and GIP receptors, which tends to produce somewhat greater average weight loss in clinical trials. A provider evaluation helps determine which is the better fit for your health profile.
Typically within a few business days of prescription approval, though exact timing can vary by location within Michigan and current pharmacy volume.
References
- U.S. Food and Drug Administration. Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide). FDA.gov. 2025. FDA Drug Approvals Database
- U.S. Food and Drug Administration. Human Drug Compounding and the FD&C Act. FDA.gov. FDA.gov
- Michigan Board of Pharmacy (LARA). Official state board of pharmacy website. https://www.michigan.gov/lara/bureau-list/bpl/health/hp-lic-health-prof/pharmacy
- Texas State Board of Pharmacy. Pharmacy license lookup and verification. pharmacy.texas.gov
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. PubMed 35658024
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. PubMed 33567185
- Mercer. National Survey of Employer-Sponsored Health Plans, 2025: GLP-1 coverage findings. Mercer.com. 2025. Mercer.com